Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBillington Regulatory News (BILN)

Share Price Information for Billington (BILN)

Share Price is delayed by 15 minutes
Get Live Data
402.50    -10.50 (-2.54%)
Bid:
395.00
Ask:
410.00
Spread: 15.00 (3.797%)
Market Cap: £51.74m
BILN Live PriceLast checked at - London Stock Exchange

Intraday Billington Share Chart

Director/PCA Dealings

13 Feb 2020 16:09

RNS Number : 9707C
Billington Holdings PLC
13 February 2020
 

13 February 2020

Billington Holdings Plc

 

("Billington", the "Group" or the "Company")

 

Director/PCA Dealings

 

The Company was notified today that Gutenga Investments PCC Limited has sold 200,000 Ordinary Shares in the Company ("Ordinary Shares") at £4.10 each per share.

 

Dr Alexander Ospelt, a director of Billington Holdings Plc, is a member of the foundation council of Gutenga Foundation which owns 100% of Gutenga Investments PCC Limited.

 

Gutenga Investments PCC Limited now holds 4,707,985 Ordinary Shares representing 36.4% of the total Ordinary Shares in issue.

 

The following notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further details.

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Gutenga Investments PCC Limited

2

Reason for the notification

a)

Position/status

Connected to Alexander Ospelt, a Non-executive Director of the Company, who is a member of the foundation council of Gutenga Foundation which owns 100% of Gutenga Investments PCC Limited.

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Billington Holdings Plc

b)

LEI

213800MUHLXWQQ6MEN67

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10p each

 

 

GB0000332667

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£4.10

200,000

 

d)

Aggregated information

- Aggregated volume

- Price

 

200,000 £4.10

e)

Date of the transaction

12 February 2020

f)

Place of the transaction

London Stock Exchange, AIM

 

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014

 

 

 

For further information please contact:

 

Billington Holdings Plc Tel: 01226 340 666

Mark Smith, Chief Executive

Trevor Taylor, Chief Financial Officer

 

WH Ireland Limited Tel: 020 7220 1666

Chris Hardie

James Sinclair-Ford

Jasper Berry

IFC Advisory Limited Tel: 020 3934 6630

Tim Metcalfe

Graham Herring

Zach Cohen

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUORNRROUUAAR
Date   Source Headline
2nd Jun 20261:14 pmRNSResult of Annual General Meeting
24th Apr 202612:31 pmRNSDirector/PDMR Dealings
23rd Apr 20267:00 amRNSDirector/PDMR Dealings
21st Apr 20267:00 amRNSResults for the year ended 31 December 2025
1st Apr 20267:00 amRNSContract Wins & Notice of Results
27th Feb 20268:50 amRNSGrant of SAYE Options and PDMR Dealings
17th Feb 20265:46 pmRNSHolding(s) in Company
16th Feb 20264:16 pmRNSHolding(s) in Company
2nd Feb 20267:00 amRNSAppointment of Independent Non-Executive Director
25th Nov 20251:23 pmRNSClosure of the Yate Facility
12th Nov 20252:11 pmRNSHolding(s) in Company
24th Oct 202511:40 amRNSDirector/PCA Dealings
14th Oct 20253:50 pmRNSProposed Closure of the Yate Facility
9th Oct 20251:37 pmRNSHolding(s) in Company
2nd Oct 20259:09 amRNSHolding(s) in Company
30th Sep 20253:02 pmRNSDirector Dealings
30th Sep 20257:00 amRNSInterim Results and Board Change
11th Sep 20257:00 amRNS-RBillington Structures Appointments
4th Aug 20257:00 amRNSDirectorate Change
3rd Jun 20253:00 pmRNSResult of AGM
13th May 202512:46 pmRNSHolding(s) in Company
6th May 20253:34 pmRNSDirector Dealings
23rd Apr 20252:29 pmRNSAwards under Company’s Long Term Incentive Plan
23rd Apr 20252:03 pmRNSAwards under the Company's Deferred Bonus Plan
15th Apr 20257:00 amRNSResults for the year ended 31 December 2024
3rd Apr 202510:04 amRNSNotice of Results and Investor Presentation
29th Jan 202511:07 amRNSHolding(s) in Company
27th Jan 20255:35 pmRNSHolding(s) in Company
22nd Jan 20257:00 amRNSIssue of Equity to Employee Share Ownership Trust
11th Dec 20247:00 amRNSTrading Update
10th Oct 20249:04 amRNSHolding(s) in Company
17th Sep 20247:00 amRNSInterim Results for the six months to 30 June 2024
12th Aug 20247:00 amRNSNotice of Results & Investor Presentation
19th Jul 202410:36 amRNSHolding(s) in Company
18th Jul 202411:29 amRNSHolding(s) in Company
17th Jul 20247:00 amRNSDirector/PCA Dealings
4th Jun 20243:15 pmRNSResult of AGM
3rd May 20249:47 amRNSAwards under Company’s Long Term Incentive Plan
22nd Apr 20249:13 amRNSDirector Dealings
18th Apr 202412:13 pmRNSAwards under the Company's Deferred Bonus Plan
16th Apr 20247:00 amRNSResults for the year ended 31 December 2023
3rd Apr 20247:00 amRNSNotice of Results & Investor Presentation
22nd Mar 20247:00 amRNS£90 million of Contracts Awarded
14th Nov 20237:00 amRNSTrading Update
19th Sep 20237:00 amRNSInterim Results for the six months to 30 June 2023
12th Sep 20237:00 amRNSBillington Structures Carbon Neutral Certification
1st Sep 20237:00 amRNSAppointment of Non-Executive Director
22nd Aug 202312:42 pmRNSNotice of Results & Investor Presentation
6th Jun 20232:55 pmRNSResult of AGM
6th Jun 20237:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.